Clinical trial
A Randomized Phase III Prospective Study of Induction Chemotherapy Combined With Concurrent Chemoradiotherapy Versus Induction Chemotherapy Combined With Radiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma
NCT05527470 is registered in ClinicalTrials.gov with Wei Jiang as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Phase III Prospective Study of Induction Chemotherapy Combined With Concurrent Chemoradiotherapy Versus Induction Chemotherapy Combined With Radiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma
- Lead sponsor
- Wei Jiang
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- November 11, 2022
- Completion date
- November 11, 2027
- Enrollment
- 440 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.